These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1937678)

  • 1. Functional derangements in the regulation of aldosterone secretion in hypertension.
    Williams GH; Hollenberg NK
    Hypertension; 1991 Nov; 18(5 Suppl):III143-9. PubMed ID: 1937678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
    Williams GH; Dluhy RG; Moore TJ
    Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension.
    Williams GH; Moore TJ; Hollenberg NK
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):423-47. PubMed ID: 1879402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered sodium perception in essential hypertensive patients following rapid volume expansion.
    Conlin P; Moore T; Williams G; Hollenberg N
    J Hum Hypertens; 1999 Oct; 13(10):701-6. PubMed ID: 10516741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid modulation of renal and adrenal responsiveness to angiotensin II.
    Conlin PR; Moore TJ; Williams GH; Hollenberg NK
    Hypertension; 1993 Dec; 22(6):832-8. PubMed ID: 7503952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Fisher ND; Hurwitz S; Ferri C; Jeunemaitre X; Hollenberg NK; Williams GH
    Hypertension; 1999 Sep; 34(3):388-94. PubMed ID: 10489382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of target tissue response to angiotensin II and sodium sensitivity in Japanese patients with essential hypertension.
    Ozono R; Matsuura H; Oshima T; Ishibashi K; Ishida M; Ishida T; Watanabe M; Kajiyama G; Kambe M
    Hypertens Res; 1996 Sep; 19(3):141-5. PubMed ID: 8891741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation in plasma renin and adrenal ANG II and aldosterone responses to sodium restriction in rats.
    Menachery A; Braley LM; Kifor I; Gleason R; Williams GH
    Am J Physiol; 1991 Oct; 261(4 Pt 1):E487-94. PubMed ID: 1928340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans.
    Gandhi SK; Ryder DH; Brown NJ
    Hypertension; 1996 Dec; 28(6):961-6. PubMed ID: 8952583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin II in the hormonal, renal, and electrolyte response to sodium restriction.
    Rogacz S; Hollenberg NK; Williams GH
    Hypertension; 1987 Mar; 9(3):289-94. PubMed ID: 3028957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. A possible model of human essential hypertension.
    Williams GH; Braley LM; Menachery A
    J Clin Invest; 1982 Jan; 69(1):31-7. PubMed ID: 6274915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
    Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE
    Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blunted aldosterone responsiveness to angiotensin II in normotensive subjects with familial predisposition to essential hypertension.
    Beretta-Piccoli C; Pusterla C; Städler P; Weidmann P
    J Hypertens; 1988 Jan; 6(1):57-61. PubMed ID: 3351294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel adrenal and renal abnormalities in young patients with essential hypertension.
    Williams GH; Tuck ML; Sullivan JM; Dluhy RG; Hollenberg NK
    Am J Med; 1982 Jun; 72(6):907-14. PubMed ID: 7091162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide in non-modulating essential hypertension.
    Luparini RL; Ferri C; Santucci A; Balsano F
    Hypertension; 1993 Jun; 21(6 Pt 1):803-9. PubMed ID: 8500861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to angiotensin II increases blood pressure and decreases salt sensitivity in rats.
    Svitok P; Senko T; Panakova Z; Olexova L; Krskova L; Okuliarova M; Zeman M
    Clin Exp Hypertens; 2017; 39(6):489-494. PubMed ID: 28737438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.